Cystic fibrosis prenatal genetic screening for high-risk populations recommended by NIH working groups.
This article was originally published in The Gray Sheet
Executive Summary
CYSTIC FIBROSIS PRENATAL GENETIC SCREENING FOR HIGH-RISK GROUPS ONLY is recommended by two National Institutes of Health working groups at an Oct. 15-16 workshop in Bethesda. Summarizing recommendations from the National Human Genome Research Institute-sponsored workshop, University of California at Los Angeles School of Medicine's Nancy Press, PhD, said on Oct. 16 that CF carrier screening should "not be offered to all populations, but rather to populations who are at high risk."